和元生物：联合专业机构拟出资不超过1亿元设产业基金，深耕细胞与基因治疗产业链

Core Viewpoint - The company plans to establish an industrial merger and acquisition fund named Heyuan Hongsheng Industrial Investment Fund Partnership, focusing on investments in the cell and gene therapy industry chain and related upstream and downstream sectors [1] Fund Details - The targeted fundraising scale for the fund is set at 500 million yuan, with the company intending to contribute no more than 100 million yuan of its own funds, representing approximately 20% of the total fundraising scale [1]